Company intelligence / Profile preview
Nacuity Pharmaceuticals
Fort Worth, Texas, USAnacuity.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Nacuity Pharmaceuticals has completed Phase 1 safety studies with its lead candidate NPI‑001 in healthy volunteers. Multiple ongoing Phase 1/2 clinical trials are underway for retinitis pigmentosa associated with Usher syndrome, cataract progression delay via intravitreal implant, nephropathic cystinosis treatment via oral dosage form, and an ophthalmic insert for ocular effects of cystinosis. The company has received orphan drug designations and Fast Track status from the FDA for key programs. No serious adverse events have been reported to date in early clinical studies.
- Therapeutic areas
- OphthalmologyNeurologyNephrology
- Modalities
- Small molecules (notably N-acetylcysteine amide [NACA] and analogs)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Foundation Fighting Blindness & RD Fund are major backers/investorsacademic collaborations not explicitly listed but implied by rare disease focus and grant support.
Beyond the preview
Go deeper on Nacuity Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nacuity Pharmaceuticals.